Mucinous ovarian cancer: A therapeutic review
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference139 articles.
1. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J. Clin. Oncol.,2012
2. Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience;Alexandre;Ann. Oncol.,2010
3. Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study;Andersson;J. Clin. Oncol.,2011
4. CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR;Andre;Eur. J. Cancer,1999
5. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J. Clin. Oncol.,2009
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular alterations in mucinous ovarian tumors – a review;Current Issues in Pharmacy and Medical Sciences;2024-09-01
2. A nomogram to predict platinum-sensitivity and survival outcome in women with advanced epithelial ovarian cancer;Taiwanese Journal of Obstetrics and Gynecology;2024-09
3. Multimodal diagnostic strategies and precision medicine in mucinous ovarian carcinoma: a comprehensive approach;Frontiers in Oncology;2024-07-08
4. A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma;NAR Genomics and Bioinformatics;2024-07-02
5. Giant mucinous cystadenocarcinoma of ovary in a young woman: a case report and review of literature;Frontiers in Oncology;2024-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3